tannins has been researched along with Kidney-Failure--Chronic* in 3 studies
1 review(s) available for tannins and Kidney-Failure--Chronic
1 trial(s) available for tannins and Kidney-Failure--Chronic
2 other study(ies) available for tannins and Kidney-Failure--Chronic
Article | Year |
---|---|
Serum aluminum levels in dialysis patients after sclerotherapy of internal hemorrhoids with aluminum potassium sulfate and tannic acid.
Aluminum potassium sulfate and tannic acid (ALTA) is an effective sclerosing agent for internal hemorrhoids. However, it is contraindicated for patients with chronic renal failure on dialysis, because the aluminum in ALTA can cause aluminum encephalopathy when it is not excreted effectively. We conducted this study to measure the serum aluminum concentrations and observe for symptoms relating to aluminum encephalopathy in dialysis patients after ALTA therapy.. Ten dialysis patients underwent ALTA therapy for hemorrhoids. We measured their serum aluminum concentrations and observed them for possible symptoms of aluminum encephalopathy.. The total injection volume of ALTA solution was 31 mL (24-37). The median serum aluminum concentration before ALTA therapy was 9 μg/L, which increased to 741, 377, and 103 μg/L, respectively, 1 h, 1 day, and 1 week after ALTA therapy. These levels decreased rapidly, to 33 μg/L by 1 month and 11 μg/L by 3 months after ALTA therapy. No patient suffered symptoms related to aluminum encephalopathy.. Although the aluminum concentrations increased temporarily after ALTA therapy, dialysis patients with levels below 150 μg/L by 1 week and thereafter are considered to be at low risk of the development of aluminum encephalopathy. Topics: Aged; Aged, 80 and over; Alum Compounds; Aluminum; Biomarkers; Contraindications; Dialysis; Female; Hemorrhoids; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neurotoxicity Syndromes; Risk; Sclerosing Solutions; Sclerotherapy; Tannins | 2014 |
[Experimental study in treating chronic renal failure with dry extract and tannins of herba ephedra].
The effects of dry extract and tannin of Herba Ephedra on adenine-induced chronic renal failure in rats and their mechanisms of action have been studied. Dry extract of Herba Ephedra in dose of 10 mg, 20 mg and 30 mg/d with adenine (for 24 days) were administered to rats. After inducing renal failure (34 days), it reduced toxins in blood significantly. The action of 30 mg-dose was highly significant, BUN decreased by 37%, creatinine (Cr) 35%, methylguanidine (MG) 76%, guanidinosuccinic acid 83%, blood phosphate 39%, while blood calcium raised for 28%. But in 25mg and 45mg-dose, MG in urine decreased by 49%-65%. The mechanisms of action might be including (1) Inhibiting the production of Cr; (2) Inhibiting the production of hydroxyl free radical, blocking the conversion of Cr into creatol, thereby reducing, the production of MG from creatol. In conclusion, dry extract of Herba ephedra could improve renal function in adenine-induced chronic renal failure in rats, correct Ca and P disorder, and especially inhibit the production of MG. Fraction 2 and fraction 3 of Ephedra tannin had no effect on this renal failure model. Topics: Adenine; Animals; Drugs, Chinese Herbal; Kidney Failure, Chronic; Male; Methylguanidine; Rats; Rats, Wistar; Tannins | 1994 |